secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001479681-25-000058
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health reports Q2 prelim revenue $244M (+221% YoY); announces $25M buyback, delays 10-Q
--------------------------------------------------------------------------------

- Q2 2025 total revenue $244.0M, up 220.7% from $76.1M in Q2 2024; gross profit $124.9M (51.2% margin) vs $22.6M (29.7%).
- Hospital visits 45,573 (+10.6% YoY); mature hospital visits up 0.6%.
- Delays 10-Q filing due to non-cash accounting adjustments for stock-based compensation on under-construction hospitals; expects to file within 5-day grace period.
- Board authorizes stock repurchase program of up to $25.0M over six months, to commence after 10-Q filing, to offset dilution from stock compensation.
- Cancels previously scheduled August 15 conference call; will reschedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000058/0001479681-25-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000058/nutx-20250814.htm
  HTML page:      https://secwatch.observer/filing/0001479681-25-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer